Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0370
-0.0009 (-2.37%)
At close: Apr 15, 2026
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $4.97 million as of April 16, 2026. Its market cap has decreased by -61.08% in one year.
Market Cap
4.97M
Enterprise Value
5.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 4.97M, a decrease of -80.51%. That is a compound annual growth rate of -19.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 5.10M | -37.50% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NKGen Biotech | 7.84M |
| Curative Biotechnology | 7.74M |
| BetterLife Pharma | 7.43M |
| Synlogic | 7.31M |
| Nymox Pharmaceutical | 6.12M |
| Mosaic ImmunoEngineering | 5.03M |
| Biomind Labs | 4.34M |
| AccuStem Sciences | 4.26M |